Granules India received ANDA approval for Guaifenesin and Pseudoephedrine Hydrochloride ER
Granules now have a total of 51 ANDA approvals from US FDA (49 Final approvals and 2 tentative approvals).
Granules now have a total of 51 ANDA approvals from US FDA (49 Final approvals and 2 tentative approvals).
Carbamazepine Tablets are indicated for use as an anticonvulsant drug and in the treatment of the pain associated with true trigeminal neuralgia
The drug is expected to cater to the fast growing Rheumatoid Arthritis, Plaque Psoriasis, JIA, Psoriatic Arthritis, Ankylosing Spondylitis, Ulcerative Colitis, Crohns disease, HS and Uveitis markets
The estimated capex is to the tune of Rs. 140 crore to be funded through debt and internal accrual
MeitY will provide technical support for digitalisation of the Ayush Sector under the Ayush Grid project for a period of three years
The Sri Sathya Sai Sanjeevani Super Speciality Hospital in Batticaloa will begin its operations by conducting free paediatric cardiac care surgeries and interventions in the next few days
Both the plants have a total Capex of Rs. 75 crore and expected production timeline is Q3 FY23
Sandu Kumarvin is an Ayurvedic digestive and immunity booster for children and also offers several other benefits.
he US FDA has issued six observations pursuant to the completion of the audit.
Pawar also unveiled the India Family Planning 2030 vision document and launched the Medical Eligibility Criteria (MEC) Wheel Application, E-Module of Family Planning Logistics Management System (FPLMIS) and Digital Archive on Family Planning under the category of Digital Intervention.
Subscribe To Our Newsletter & Stay Updated